AbbVie wins FDA approval for new antibiotic
The FDA approved AbbVie and Pfizer's drug Emblaveo in combination with an older antibiotic to treat complicated intra-abdominal infections. AbbVie, which owns the US commercial rights to the antibiotic, said
The FDA approved AbbVie and Pfizer's drug Emblaveo in combination with an older antibiotic to treat complicated intra-abdominal infections.
AbbVie, which owns the US commercial rights to the antibiotic, said
